Showing results (1141-1150 of 5,142) with videos related to

Sort By:
Pageof 515
The Journal of Infection|February 14, 2025
Increasing child vaccination coverage can reduce influenza cases across age groups: An agent-based modeling studyKatherine V Williams, Mary G Krauland, Mary Patricia Nowalk, et al.
The Journal of Infection|November 16, 2024
The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years oldC McLeod, M Dymock, K L Flanagan, et al.
The Journal of Infection|October 31, 2024
High rates of Dientamoeba fragilis and Blastocystis species in children's stool but minor clinical significanceDavid Shasha, Orit Treygerman, Etti Levy Dahari, et al.
The Journal of Infection|November 9, 2024
Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in ChinaBing Han, Chunling Du, Min Deng, et al.
The Journal of Infection|November 3, 2024
Near real-time severe acute respiratory illness surveillance characterising influenza and COVID-19 epidemiology in hospitalised adults, 2021-22Antonia Ho, Neil McInnes, Andrew Blunsum, et al.
The Journal of Infection|March 6, 2025
A human-infecting H10N5 avian influenza virus: Clinical features, virus reassortment, receptor-binding affinity, and possible transmission routesJing Yang, Shufa Zheng, Ju Sun, et al.
The Journal of Infection|March 9, 2025
Genomic epidemiology and antimicrobial resistance reveal local transmission dynamics of enteric fever in Shenzhen, one of the mega cities in ChinaYixiang Jiang, Min Jiang, Xin Lu, et al.
The Journal of Infection|October 25, 2024
Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals modelsMichael P Citron, Xiaowei Zang, Andrew Leithead, et al.
The Journal of Infection|October 19, 2024
Inflammatory cytokine responses in pediatric tuberculosis with or without SARS-CoV-2 seropositivityNathella Pavan Kumar, Sarath Balaji, Poorna Ganga Devi, et al.
The Journal of Infection|October 18, 2024
Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trialXinhua Chen, Xing Meng, Qianhui Wu, et al.
Pageof 515